Search clinical trials for: ATx201 2% Cream
Total 17465 results
-
UNION therapeuticsCompletedAtopic DermatitisCanada
-
UNION therapeuticsCompletedIrritation Potential of Topic AgentUnited States
-
Amicus TherapeuticsAvailable
-
UNION therapeuticsCompletedAtopic DermatitisBulgaria, Denmark, Poland
-
UNION therapeuticsCompleted
-
UNION therapeuticsCompleted
-
UNION therapeuticsCompleted
-
Amicus TherapeuticsAvailablePompe Disease Infantile-OnsetTaiwan, United States, Italy
-
PfizerCompleted
-
PfizerCompletedFungal InfectionNetherlands
-
LEO PharmaCompletedImpetigo | Secondarily Infected Traumatic Lesions (SITL)United States
-
Betta Pharmaceuticals Co., Ltd.Quintiles, Inc.Completed
-
University of ParmaCompletedInflammatory Response | Endotoxemia | Oxidative Stress | Glucose, High BloodItaly
-
Taro Pharmaceuticals USACompleted
-
Jamaica Hospital Medical CenterJohnson & JohnsonUnknownTinea Pedis | Athlete's Foot | Foot Fungus | RingwormUnited States
-
AlgoTherapeutixRecruitingChemotherapy-induced Peripheral NeuropathyUnited States, Spain, Belgium, France, Czechia, Poland, Italy
-
Graceway Pharmaceuticals, LLCCompletedGenital WartsUnited States
-
Rutgers, The State University of New JerseyCenters for Disease Control and PreventionCompletedViolence | Helping Behavior | Sexual Assault and Rape | Assaultive BehaviorUnited States
-
GlaxoSmithKlineCompleted
-
LUTRONIC CorporationCompleted
-
Chulalongkorn UniversityNot yet recruiting
-
Ambrx, Inc.Merck Serono International SACompletedGrowth Hormone DeficiencyHungary
-
Merz North America, Inc.CompletedTinea CorporisUnited States, Dominican Republic, Honduras
-
Northwestern UniversityCompletedAcne VulgarisUnited States
-
Sol-Gel Technologies, Ltd.Completed
-
LEO PharmaCompletedSecondarily Infected Traumatic Lesions | ImpetigoUnited States, South Africa
-
Medical University of South CarolinaCompletedActinic PorokeratosisUnited States
-
Sol-Gel Technologies, Ltd.Completed
-
Tinea PharmaceuticalsCompletedTinea PedisUnited States
-
University of North Carolina, CharlotteTeva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States
-
Incyte CorporationCompletedCutaneous Lichen PlanusUnited States, Canada
-
BayerUltragenix pharmaceuticalActive, not recruitingHemophilia ANetherlands, United States, Germany, United Kingdom, France, Bulgaria
-
ACO Hud Nordic ABThe University of Sheffield Medical SchoolCompletedDermatitis, AtopicUnited Kingdom
-
Baliopharm Pty LtdCompletedHealthy VolunteersAustralia
-
Incyte CorporationRecruitingPrurigoUnited States, Spain, France, Poland, Germany, Belgium, Netherlands, Argentina, Italy, Canada, Chile, Brazil
-
Encoded TherapeuticsRecruiting
-
Encoded TherapeuticsRecruiting
-
Coeptis TherapeuticsFred Hutchinson Cancer CenterCompletedCOVID-19 PneumoniaUnited States
-
Xilio Development, Inc.Active, not recruiting
-
Coegin Pharma ABBispebjerg Hospital; Studies&MeActive, not recruiting
-
Seaside Therapeutics, Inc.CompletedFragile X SyndromeUnited States
-
Amicus TherapeuticsTerminatedType 1 Gaucher DiseaseUnited States, United Kingdom
-
Edesa Biotech Inc.JSS Medical Research Inc.Active, not recruitingAllergic Contact DermatitisUnited States, Canada
-
LEO PharmaCompletedChronic Hand EczemaUnited States, Germany, Denmark
-
LEO PharmaCompletedHealthy VolunteersGermany
-
Encoded TherapeuticsRecruiting
-
Xilio Development, Inc.Recruiting
-
Almac DiscoveryTerminatedOvarian Cancer | Solid TumorsUnited Kingdom
-
Seaside Therapeutics, Inc.CompletedFragile X SyndromeUnited States
-
LEO PharmaTerminatedDiscoid Lupus ErythematosusUnited States, France, Germany, Denmark